IMMB OTC
Immunotech Laboratories, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +100.0%
1Y: +100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$306K
+0.0% ▲
Operating Income
-$470K
+0.0% ▲
Net Income
-$493K
+0.0% ▲
EPS (Diluted)
$-0.00
+0.0% ▲
EBITDA
-$454K
+0.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2004 | FY2005 | FY2009 | FY2013 | FY2016 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | -100.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $547K | $306K |
| Gross Profit | $0 | $0 | $0 | -$547K | -$306K |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $0 | $0 | $254K | $0 | $0 |
| SG&A Expenses | $107K | $2M | $690K | $56K | $165K |
| Operating Expenses | $110K | $2M | $959K | $56K | $165K |
| Operating Income | -$110K | -$2M | -$959K | -$603K | -$470K |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $0 | $0 | $19K | $23K | $23K |
| Income Before Tax | -$110K | -$34M | -$978K | -$626K | -$493K |
| Tax Expense | $800 | $800 | $0 | $0 | $0 |
| Net Income | -$111K | -$34M | -$978K | -$626K | -$493K |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-43.00 | $-802.00 | $0.00 | $-0.00 | $-0.00 |
| EBITDA | -$110K | -$2M | -$945K | -$589K | -$454K |
| Shares Outstanding | 2574 | 41882 | 0 | 438M | 573M |